This compound is a protected derivative of 4-hydroxy-L-proline, featuring both tert-butoxycarbonyl (Boc) and tert-butyl ester protecting groups. It is primarily employed as a building block in solid-phase peptide synthesis, enabling the incorporation of hydroxyproline residues while preventing unwanted side reactions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 170850-75-6
N-Boc-trans-4-Hydroxy-L-proline methyl ester
pharmaceutical intermediate
N-Boc-cis-4-Hydroxy-L-proline methyl ester
pharmaceutical intermediate
Methyl cis-1-Boc-4-hydroxy-D-prolinate
pharmaceutical intermediate
Cis-N-boc-4-hydroxy-L-proline
pharmaceutical intermediate
2,4,6-Tribromo-1-oxo-1λ⁵-pyridine
pharmaceutical intermediate
1-((2-(dimethoxymethyl)-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)methyl)-4-methylpiperazin-2-one
pharmaceutical intermediate
Benzyl (3S,4R)-3-ethyl-4-(3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate
pharmaceutical intermediate
3-Aminobenzaldehyde
pharmaceutical intermediate
ditert-butyl (2S,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate
OXHIVNUWGSCHBD-ZJUUUORDSA-N
CC(C)(C)OC(=O)[C@@H]1C[C@H](CN1C(=O)OC(C)(C)C)O